Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 3
2005 4
2006 2
2007 7
2008 5
2009 6
2010 6
2011 10
2012 6
2013 7
2014 11
2015 15
2016 25
2017 19
2018 23
2019 18
2020 17
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

169 results
Results by year
Filters applied: . Clear all
Page 1
Alcoholic liver disease.
Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, Mathurin P, Mueller S, Szabo G, Tsukamoto H. Seitz HK, et al. Among authors: gual a. Nat Rev Dis Primers. 2018 Aug 16;4(1):16. doi: 10.1038/s41572-018-0014-7. Nat Rev Dis Primers. 2018. PMID: 30115921 Review.
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, et al. J Hepatol. 2018 Jul;69(1):154-181. doi: 10.1016/j.jhep.2018.03.018. Epub 2018 Apr 5. J Hepatol. 2018. PMID: 29628280 Review. No abstract available.
Safety of nalmefene for the treatment of alcohol use disorder: an update.
López-Pelayo H, Zuluaga P, Caballeria E, Van den Brink W, Mann K, Gual A. López-Pelayo H, et al. Among authors: gual a. Expert Opin Drug Saf. 2020 Jan;19(1):9-17. doi: 10.1080/14740338.2020.1707802. Epub 2019 Dec 30. Expert Opin Drug Saf. 2020. PMID: 31868031
"The post-COVID era": challenges in the treatment of substance use disorder (SUD) after the pandemic.
López-Pelayo H, Aubin HJ, Drummond C, Dom G, Pascual F, Rehm J, Saitz R, Scafato E, Gual A. López-Pelayo H, et al. Among authors: gual a. BMC Med. 2020 Jul 31;18(1):241. doi: 10.1186/s12916-020-01693-9. BMC Med. 2020. PMID: 32731868 Free PMC article.
Psychoactive constituents of cannabis and their clinical implications: a systematic review.
Casajuana Köguel C, López-Pelayo H, Balcells-Olivero MM, Colom J, Gual A. Casajuana Köguel C, et al. Among authors: gual a. Adicciones. 2018 Apr 15;30(2):140-151. doi: 10.20882/adicciones.858. Adicciones. 2018. PMID: 28492950 Free article. English, Spanish.
Alcohol Control Policy in Europe: Overview and Exemplary Countries.
Berdzuli N, Ferreira-Borges C, Gual A, Rehm J. Berdzuli N, et al. Among authors: gual a. Int J Environ Res Public Health. 2020 Nov 4;17(21):8162. doi: 10.3390/ijerph17218162. Int J Environ Res Public Health. 2020. PMID: 33158307 Free PMC article. Review.
[Low-risk alcohol drinking limits based on associated mortality.].
Sordo L, Córdoba R, Gual A, Sureda X. Sordo L, et al. Among authors: gual a. Rev Esp Salud Publica. 2020 Nov 13;94:e202011167. Rev Esp Salud Publica. 2020. PMID: 33185196 Free article. Review. Spanish.
Comments from the Editors on the Special Issue "Assessment and Treatment of Addictions: New Tools for Old Problems".
Barrio P, Miquel L, Gual A. Barrio P, et al. Among authors: gual a. J Clin Med. 2019 Oct 17;8(10):1717. doi: 10.3390/jcm8101717. J Clin Med. 2019. PMID: 31627454 Free PMC article.
[Detection and registration of alcohol use in the emergency department].
Bruguera P, Barrio P, Oliveras C, Vázquez M, Soler V, Nuño L, Vieta E, Gual A. Bruguera P, et al. Among authors: gual a. Rev Esp Salud Publica. 2020 Apr 8;94:e202004019. Rev Esp Salud Publica. 2020. PMID: 32382002 Free article. Spanish.
Cerebellar alterations in cannabis users: A systematic review.
Blithikioti C, Miquel L, Batalla A, Rubio B, Maffei G, Herreros I, Gual A, Verschure P, Balcells-Oliveró M. Blithikioti C, et al. Among authors: gual a. Addict Biol. 2019 Nov;24(6):1121-1137. doi: 10.1111/adb.12714. Epub 2019 Feb 27. Addict Biol. 2019. PMID: 30811097
169 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page